• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Facebook
  • Instagram
  • LinkedIn
  • TikTok
  • Twitter
  • YouTube
CDE Almería – Centro de Documentación Europea – Universidad de Almería

CDE Almería - Centro de Documentación Europea - Universidad de Almería

Centro de Documentación Europea de la Universidad de Almería

  • HOME
  • WHAT´S ON
    • EU BULLETINS
    • EU NEWS
    • Activities
    • EU Calls and Awards
    • Radio Program «Europe with You»
  • DOCUMENTATION
    • Bibliographic Collection
      • Almería EDC Digital Collection
      • UNIVERSITY OF ALMERIA LIBRARY
    • Documentation by topic
    • EU Media Collection
      • Web Space
      • MEDIATHEQUE REPOSITORY
  • Europe on the net
    • Institutions
    • EU Representation in Spain
    • European information network of Andalusia
    • EU official journal
  • ABOUT US
    • Presentation
    • People
    • Contact
  • English
  • Spanish

Follow-up and screening to improve the health of children who are born before 32 weeks of pregnancy

Inicio » EU News » Follow-up and screening to improve the health of children who are born before 32 weeks of pregnancy

19 de September de 2019

A new study from the Effective Perinatal Intensive Care in Europe (EPICE) cohort assessed the impact of follow-up and screening programmes on the health of very preterm infants after they are discharged home from the neonatal intensive care unit. The study also looked at effects on their families, assessment tools and costs to society.

Every year, about 50 000 infants in the EU survive very preterm birth and are at much higher risk of cerebral palsy, visual and auditory deficits, impaired cognitive ability, psychiatric disorders and behavioural problems than infants born at term. “The ultimate goal of the SHIPS (Screening to improve Health In very Preterm infantS in Europe) project is to ensure that babies receive high-quality healthcare after they are discharged home from the neonatal intensive care unit,” outlines project coordinator Dr Jennifer Zeitlin.

Wide range of programmes with varying levels of parental satisfaction

To assess the range of follow-up programmes in Europe, SHIPS researchers contacted the parents of children in the EPICE study when they were 5 years old. This cohort includes very preterm children born in 19 regions in 11 EU countries in 2011 and 2012. Of the 3 674 parents who responded, 62 families were chosen for in-depth qualitative interviews and 1 654 children born before 28 weeks gestation were clinically assessed.

About 90 % of parents rated their very preterm children’s health as good or excellent and their development as average or in advance. Overall, the clinical assessments of the children’s neurodevelopment corroborate these positive findings.

“However, the study revealed families struggling because their children have severe impairments and health problems,” continues Dr Zeitlin. Even for children without severe problems, parents voiced multiple concerns about their health and development, notably related to behavioural and mental health issues. “We found that 8 % of children had received no follow-up, which is an undesirable outcome,” she concludes.

“SHIPS also documented the current policy context, which is highly variable from one country to another,” explains Dr Zeitlin. Some countries have no formal follow-up programmes, while others provide organised follow-up services for children up to 8 years of age.

 

Valuable parental feedback

Parents’ opinions about the difficulties they faced obtaining high-quality follow-up care in the project surveys and qualitative studies can be used by policymakers, clinicians, healthcare professionals and parents to advocate for better programmes.

Difficulties highlighted were more acute for the most fragile families with employment, financial and social difficulties. These include problems at the time of discharge; coordination of follow-up between health and development check-ups and specialist visits; the lack of a reference person; and especially the lack of protected access to treatment for problems diagnosed during follow-up, with long waiting times.

The future for SHIPS starting with a workshop in September 2019.

“Although the project ended in January 2019, SHIPS data are still being analysed and the consortium has put into place a process for developing clinical recommendations,” points out Dr Zeitlin. She continues: “The first step is an international workshop on the SHIPS results at the jENS – 3rd Congress of joint European Neonatal Societies mid-September 2019 in Maastricht.” Publications needed for these recommendations are in preparation on neurodevelopmental impairment in the cohort, the impact of parents’ social circumstances on their use of care facilities, and their health and development and the costs of care.

“For the future, we are evaluating the possibility of recontacting families in the cohort when the children are 11 or 12 years of age. This is a good time to see how children are developing in school, which is a key concern of parents,” Dr Zeitlin emphasises.

More information

Access the full news

SHIPS

jENS – 3rd Congress of joint European Neonatal Societies

More information in the Research and Innovation Section

Publicaciones relacionadas:

MyNewGut project: The role of our gut biome in our health and well-being Project INTRICARE: The role of vitamin K in cardiovascular health and bone strength A mobile app that saves lives: remote symptom monitoring for cancer patients Why stem cells could hold key to tackling breast cancer First vaccine to protect against Ebola

“This is a space for debate. All comments, for or against publication, that are respectful and do not contain expressions that are discriminatory, defamatory or contrary to current legislation will be published”.

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Primary Sidebar

Publicaciones relacionadas


MyNewGut project: The role of our gut biome in our health and well-being


Project INTRICARE: The role of vitamin K in cardiovascular health and bone strength


A mobile app that saves lives: remote symptom monitoring for cancer patients


Why stem cells could hold key to tackling breast cancer


First vaccine to protect against Ebola

Footer

Logotipo en negativo del Centro de Documentación Europea de Almería
  • CDE Almería
  • Edificio Parque Científico-Tecnológico (Pita)
  • Planta: 1ª, Despacho: 2904120.
  • Ctra. Sacramento s/n. Almería (Spain)
  • Teléfono: (+34) 950 015266

HOME
NEWS
DOCUMENTATION
EUROPE ON THE NET
ABOUT US

  • LEGAL NOTICE
  • PRIVACY POLICY
  • COOKIE POLICY
  • ACCESSIBILITY
  • SITEMAP

Copyright © 2023 CDE Almería · Creative Commons LicenseThis work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

<p>El Centro de Documentación Europea de la Universidad de Almería utiliza cookies propias y de terceros para facilitar al usuario la navegación en su página Web y el acceso a los distintos contenidos alojados en la misma. Asimismo, se utilizan cookies analíticas de terceros para medir la interacción de los usuarios con el sitio Web. Pinche el siguiente enlace si desea información sobre el uso de cookies y como deshabilitarlas. ajustes</p>

Politica de privacidad

El Centro de Documentación Europea de la Universidad de Almería utiliza cookies propias y de terceros para facilitar al usuario la navegación en su página Web y el acceso a los distintos contenidos alojados en la misma. Asimismo, se utilizan cookies analíticas de terceros para medir la interacción de los usuarios con el sitio Web. Pinche el siguiente enlace si desea información sobre el uso de cookies y como deshabilitarlas. <a href="/politica-de-cookies" rel="noopener" target="_blank">Más información</a>

Cookies estrictamente necesarias

Las cookies estrictamente necesarias tiene que activarse siempre para que podamos guardar tus preferencias de ajustes de cookies.

Básicamente la web no funcionara bien si no las activas.

Estas cookies son:

  • Comprobación de inicio de sesión.
  • Cookies de seguridad.
  • Aceptación/rechazo previo de cookies.

Si desactivas esta cookie no podremos guardar tus preferencias. Esto significa que cada vez que visites esta web tendrás que activar o desactivar las cookies de nuevo.

Cookies de terceros

Esta web utiliza Google Analytics, Google Tag Manager y Yandex Metrika para recopilar información anónima tal como el número de visitantes del sitio, o las páginas más populares.

Dejar estas cookies activas nos permite mejorar nuestra web.

¡Por favor, activa primero las cookies estrictamente necesarias para que podamos guardar tus preferencias!

Política de cookies

Pinche el siguiente enlace si desea información sobre el uso de cookies y como deshabilitarlas. Más información